ProHealth Arthritis Research and News

St John's wort greatly reduces the concentrations of oral oxycodone Source: European Journal of Pain, Sep 2010

feeds@prohealth.com (Tuija H Nieminen, et al.) — Sat, 28 Aug 2010 01:00:01 PDT

Taking St John's wort for depression halves the pain relieving effect/duration of the opioid drug oxycodone.

Fish oil supplementation increases the cyclooxygenase inhibitory activity of paracetamol [acetaminophen] in rheumatoid arthritis patients - Source: Complementary Therapies in Medicine, Jun-Aug 2010

feeds@prohealth.com (Gillian E Caughey, et al.) — Sat, 28 Aug 2010 01:00:01 PDT

Supplementary fish oil boosts acetaminophen's pain reducing impact, may reduce needed dose.

RA 'signaling protein' reverses Alzheimer's plaque & memory loss in animals: Major breakthrough seen

feeds@prohealth.com (x) — Wed, 25 Aug 2010 01:00:01 PDT

Pilot trial for mild/moderate Alzheimer's patients planned at U of South Florida.

From Our Readers - Comments & Suggestions - 08-25-10

feeds@prohealth.com (x) — Wed, 25 Aug 2010 01:00:01 PDT

Sharing information on depression, menopause, blood pressure, pain medication, brain fog, asthma, drug costs and warnings, and much more.

A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution Source: Genome Research, Aug 24, 2010

feeds@prohealth.com (SV Ramagopalan, et al.) — Tue, 24 Aug 2010 01:00:01 PDT

Genome analysis finds vit D significantly affects 2776 genomic positions and 229 genes - with intense activity near autoimmune and cancer-associated genes.

Lipid replacement therapy: A nutraceutical approach for reducing cancer-associated fatigue and the adverse effects of cancer therapy while restoring mitochondrial function Source: Cancer Metastasis Review, Aug 19, 2010

feeds@prohealth.com (Garth L Nicolson ) — Sat, 21 Aug 2010 01:00:01 PDT

Certain nutraceuticals including directly usable lipids may bolster the structure & function of cells compromised by cancer therapy.

Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: A randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety Source: BMC Medicine, Aug 16, 2010

feeds@prohealth.com (Alan G Wade, et al.) — Fri, 20 Aug 2010 01:00:01 PDT

Melatonin is highly likely to offer 'significant positive effects with excellent tolerance' in older persons with insomnia. It can help many younger ones too, but response can't be predicted by endogenous melatonin testing because 'normal' varies so greatly.

CFIDS Assoc. Disability Nuts & Bolts Webinar, Aug 19, 1 pm EDT, 10 am Pacific

feeds@prohealth.com (x) — Wed, 18 Aug 2010 01:00:01 PDT

Understanding and meeting disability coverage requirements. Register NOW.

Major study confirms, B Vitamins friend of the aging brain and healthy mood

feeds@prohealth.com (x) — Wed, 18 Aug 2010 01:00:01 PDT

Series of�discoveries verifies B vitamins directly linked to sustained brain health.

FDA Puts Off Revised Opioid Risk Control Policy Introduction

feeds@prohealth.com (x) — Wed, 18 Aug 2010 01:00:01 PDT

Pain treatments expert Dr. Stewart B Leavitt lays out the issues, and stakes for chronic pain patients.